Welcome to our
IPSEN Pro website
Therapeutic Areas

Oncology
Renal Cell Cancer
Prostate Cancer
Neuroendocrine Tumours

Neuroscience
Cervical Dystonia

Product Portfolio & Pipeline


Diphereline®
(triptorelin embonate)


Iqirvo® (elafibranor)

Sohonos® (palovarotene)

Somatuline® Autogel® (lanreotide acetate)



Our R&D strategy for a thriving product pipeline
As a global biopharmaceutical company with a focus on innovation and specialty care, Ipsen is building a strong and sustainable portfolio of medicines to meet patients’ and their healthcare teams’ needs. We prioritize best-in-class and first-in-class treatments in oncology, rare disease, and neuroscience – areas in which we have proven experience, global capabilities, and a strong network of partners.
Read More